Sridharan Rajagopal

This inventor holds 13 USPTO granted patents and 3 published patent applications and 7 EPO patents, primarily in Medicinal Chemistry. Top assignees: Jubilant Biosys Limited, Jubilant Epipad LLC, Jubilant Epicore LLC. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sridharan Rajagopal. Retrieved from https://idiyas.com/inventor/sridharan-rajagopal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 92.3

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Yeshwanthpur Bangalore, IN (2022)
Bengaluru, IN (2020 - 2023)

Company Filing History:

4 out of 5

Jubilant Biosys Limited

Blueprint Medicines Corporation

patents

5. 1 out of 1

Jubilant Episcribe LLC

7. 1 out of 834,708

Other

patents

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

Pyrimidine Compounds

LSD1 Inhibitors

HDAC Inhibitors

PAD Inhibitors

PD1/PD-L1

Heterocyclic Compounds

Tricyclic Derivatives

BRD4 Inhibitors

Cancer Treatment

Cyclopropyl Compounds

Imidazo-Pyridine

PRMT5 Inhibitors

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686673 - Pyrimidine compounds, compositions, and medicinal applications thereof (2026-07-21),

2. 12479797 - Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors (2025-11-25),

3. 12357639 - Heterocyclic compounds as pad inhibitors (2025-07-15),

4. 11833156 - Heterocyclic compounds as pad inhibitors (2023-12-05),

5. 11629135 - Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation (2023-04-18),

6. 11529341 - Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation (2022-12-20),

7. 11459338 - Heterocyclic compounds as PRMT5 inhibitors (2022-10-04),

8. 11426412 - Imidazo-pyridine compounds as PAD inhibitors (2022-08-30),

9. 11352322 - Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors (2022-06-07),

10. 11319326 - Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer (2022-05-03),

11. 11267820 - Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors (2022-03-08),

12. 10689395 - Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors (2020-06-23),

13. 10689390 - Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer (2020-06-23),

Title: Sridharan Rajagopal - Innovator from Bengaluru

Introduction: Sridharan Rajagopal is a renowned inventor hailing from Bengaluru, India, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sridharan Rajagopal holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Sridharan Rajagopal has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Sridharan Rajagopal has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Sridharan Rajagopal's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists worldwide.

Profile summary based on public USPTO records.